9 January 2023 in World Neurosurgery
1 August 2026 in Epilepsia
Objective: This study was undertaken to evaluate the safety, feasibility, and efficacy of low‐intensity focused ultrasound (LIFU) as a noninvasive neuromodulation technique in patients with drug‐resistant epilepsy (DRE). Methods: In this pilot, single‐blind, randomized sham‐controlled crossover trial, 12 patients with DRE underwent both LIFU and sham stimulation in a randomized sequence, targeting the seizure onset zone (SOZ), each followed by a 4‐week observation period. Seizure frequency was analyzed as proportional change from baseline using linear mixed‐effects models. An open‐label extension phase evaluated longitudinal seizure outcomes following LIFU. Safety assessments included neurological examinations, magnetic resonance imaging (MRI), and neuropsychological and quality of life (QOL) measures. Results: During the crossover phase, LIFU did not significantly reduce seizure frequency compared with sham (estimate = .49, 95% confidence interval [CI] = −.04 to 1.01, p = .068). No period or sequence effects were observed. Conversely, during the open‐label extension phase, seizure frequency demonstrated a significant longitudinal reduction following LIFU (β = −14.0 percentage points per month, 95% CI = −22.2 to −5.8, p = .001). Post‐LIFU MRI showed no structural lesions. No significant changes were observed in anxiety, depression, or QOL scores. There were only transient mild‐to‐moderate adverse events reported, without serious complications. Significance: LIFU neuromodulation targeting the SOZ is safe and well tolerated. Although the primary crossover analysis did not demonstrate a statistically significant antiseizure effect, delayed seizure reduction during the extended follow‐up suggests potential sustained neuromodulatory effects. Larger parallel‐group trials with longer observation periods are warranted.
14 November 2026 in World Neurosurgery: X
30 April 2025 in Neurological Surgery and Anatomy
Background Trigeminal neuralgia (TN) secondary to vertebrobasilar artery (VBA) compression is extremely rare. Macrovascular decompression is an option to address this condition. However, the unique anatomy surrounding the VBA and trigeminal nerve poses significant surgical challenges. Various approaches and techniques have been discussed in the literature. We describe the pretemporal transcavernous Kawase approach, utilizing the transposition method with Teflon and an artificial dura sling, to achieve effective decompression. Presentation We present a case of a 65-year-old male with left side medically-intractable TN secondary to dissecting basilar artery aneurysm compression. Strategy with pretemporal transcavernous Kawase approach was conducted. The trigeminal nerve was found push superiolaterally by ipsilateral deviation of VBA. The VBA was mobilized inferomedially with care to prevent perforating artery transection. A Teflon prosthesis and an artificial dura sling were interposed in neurovascular conflicting area. The left-sided TN abated immediately after the intervention, and the patient was free from medication upon discharge. Conclusion This case was effectively managed utilizing the pretemporal transcavernous Kawase approach, coupled with a unique transposition technique employing Teflon and an artificial dura sling. This approach offered significant advantages, notably enhanced visualization of the trigeminal root entry zone and improved maneuverability for repositioning the crooked basilar artery inferomedially, away from the trigeminal nerve. The utilization of Teflon and an artificial dura sling as a transposition method ensured a safe distance between the VBA and the trigeminal nerve. Consequently, an outstanding surgical outcome was achieved, characterized by complete resolution of TN resulting from dissecting basilar artery aneurysm compression.
23 September 2026 in Journal of the Formosan Medical Association